Arab Finance: Arab Drug Company’s (ADCI) net profits after tax jumped 24.2% year on year (YoY) in the fiscal year (FY) 2023/2024, according to the company’s audited financial statement.
Net profits after tax recorded EGP 102.824 million last FY, up from EGP 82.77 million a year earlier.
Meanwhile, total revenues rose to EGP 785.522 million from EGP 633.733 million.
Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.